Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study - Concepedia

Concepedia

Publication | Open Access

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

DOI Full Paper Access

24

Citations

22

References

2022

Year

Carmen Alcalá, Carlos Quintanilla‐Bordás, Francisco Gascón, Ángel Pérez Sempere, Laura Navarro-Cantó, María Carcelén‐Gadea, Lamberto Landete, Javier Mallada, Emmanuel Cañizares, Antonio Belenguer,

Journal of Neurology

RheumatologyMedicineClinical NeurologyClinical TrialsNeurological ProgressPharmacotherapyNeurologyMultiple SclerosisNeuroimmunologyReal-world Observational Study

References

	Year	Citations

Page 1

Page 1